SEC Form 4 · accession 0001209191-16-105821
CERUS CORP · CERS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Benjamin
Officer — Chief Medical Officer
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 8:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001020214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F2,F1 | $5.06 | Mar 1, 2016 | A | 45,000 | A | — | Feb 28, 2026 | Common Stock | 45,000 | 45,000 | D |
| Restricted Stock UnitF2,F3,F4 | — | Mar 1, 2016 | A | 9,000 | A | — | — | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter.
- F2Not applicable.
- F3Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
- F4The restricted stock unit vests in three equal annual installments beginning on March 10, 2017.